Recruiting

Observational Study

Sponsor:

Stanford University

Code:

NCT02269865

Conditions

Myotonic Dystrophy Type 1

Eligibility Criteria

Sex: All

Age: 8 - 17

Healthy Volunteers: Accepted

Study Details

Brief summary:

Study to focus on the defining and managing the neuropsychological abnormalities of myotonic dystrophy and to find out if the neuropsychological abnormalities have any correlation with changes seen on Magnetic Resonance Imaging.

Conditions

Myotonic Dystrophy Type 1

Study ID

NCT02269865

Start date

Dec, 2013

Status verified date

Oct, 2014

Completion date

Dec, 2016

Anticipated

Primary completion date

Dec, 2016

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 8 - 17

Healthy Volunteers: Accepted

Inclusion Criteria:

  • 20 subjects with Myotonic Dystrophy type 1 aged 8 to 17 years and 20 controls who are healthy volunteers or siblings of affected subjects.

Exclusion Criteria:

-

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Define the neuropsychological abnormalities in Myotonic Dystrophy type 1 [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

John W Day, MD, PhD

650-725-4341jwday@stanford.edu

Locations

Lucile Packard Childrens Hospital, Stanford

Recruiting

Stanford, California, United States, 94304

Contacts

John W Day, MD, PhD

650-725-4341jwday@stanford.edu

More Information

Sponsor

Stanford University

Last update posted

Oct 21, 2014

Last verified

Oct, 2014

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stanford University on 2014-10-21.